Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Topotecan
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Topotecan 1mg capsules
0801050AFAAADAD
|
Topotecan | Topotecan | Malignant Disease and Immunosuppression | No data available |
|
Topotecan 1mg powder for solution for infusion vials
0801050AFAAAAAA
|
Topotecan | Topotecan | Malignant Disease and Immunosuppression | No data available |
|
Topotecan 1mg/1ml solution for infusion vials
0801050AFAAAFAF
|
Topotecan | Topotecan | Malignant Disease and Immunosuppression | No data available |
|
Topotecan 250microgram capsules
0801050AFAAACAC
|
Topotecan | Topotecan | Malignant Disease and Immunosuppression | No data available |
|
Topotecan 4mg powder for solution for infusion vials
0801050AFAAABAB
|
Topotecan | Topotecan | Malignant Disease and Immunosuppression | No data available |
|
Topotecan 4mg/4ml solution for infusion vials
0801050AFAAAEAE
|
Topotecan | Topotecan | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.